Immunopeptidomics Powers Vaccine Design and Target Discovery
- Detection compatible with multiple human and mouse HLA/MHC types
- Enrichment and quantification of peptides at the single-cell-level input scale
- Accurate HLA typing combined with peptide database matching
- Integrated analysis of peptidomics, proteomics, and transcriptomics to improve target screening efficiency
Vaccine design has traditionally relied on protein sequence-based prediction and immunological assays. However, when applied to complex biological contexts, such as viral variants or tumor neoantigens, this strategy is often constrained by insufficient precision in antigen identification. Immunopeptidomics, an emerging field that integrates mass spectrometry with immunobiology, is providing innovative approaches for efficient vaccine design and precise target discovery.
What Is Immunopeptidomics?
1. Core Concept
Immunopeptidomics refers to the systematic mass spectrometry-based analysis of endogenous peptides presented by major histocompatibility complex (MHC) molecules. This approach enables the identification of naturally presented antigens that can be recognized by T cells under physiological immune conditions. It can be used to characterize antigen presentation profiles across diverse biological and disease states, including viral infection, cancer, and immune-mediated disorders.
2. Differences From Traditional Prediction Methods
Traditional approaches rely on bioinformatic prediction to identify potential T-cell epitopes. However, substantial discrepancies may exist between predicted epitopes, actual MHC loading, and T-cell receptor (TCR) recognition. In contrast, immunopeptidomics directly enriches MHC complexes and profiles the associated peptide repertoire, generating data with greater physiological relevance and markedly improving the accuracy of target screening.
Technical Workflow: Precise Analysis From Cells to Antigenic Peptides
1. Key Steps Include
(1) MHC Immunoprecipitation: Specific antibodies are used to enrich target MHC molecules.
(2) Peptide Elution and Purification: MHC-bound peptides are eluted and purified under non-denaturing conditions to minimize protein contamination.
(3) High-Resolution Mass Spectrometry Detection: High-sensitivity analysis is performed using platforms such as Orbitrap or TIMS-TOF mass spectrometry.
(4) Database Matching and Identification: HLA typing information is integrated with database searching to support peptide sequence assignment and source protein annotation.
2. Challenges and Strategies
(1) Diverse MHC Types, Accurate Matching of Individual HLA Types Is Required
Because MHC molecules are highly polymorphic, precise matching of individual HLA types is essential for reliable peptide identification and interpretation.
(2) Extremely Low Peptide Abundance, Sample Preparation, and Mass Spectrometry Sensitivity Are Critical
MHC-presented peptides are typically present at very low abundance, making efficient sample preparation and highly sensitive mass spectrometric detection key determinants of analytical performance.
(3) Complex Data Analysis, Specialized Algorithms, and Curated Databases Are Required
Immunopeptidomics data interpretation requires dedicated computational algorithms, HLA-aware search strategies, and experience-based databases to improve identification confidence and biological annotation.
Application Scenarios: The Multifaceted Value of Immunopeptidomics in Vaccine Design
1. Antigen Identification and Mutation Monitoring in Viral Vaccines
In the development of viral vaccines, including influenza and SARS-CoV-2 vaccines, immunopeptidomics can identify epitope peptides that are truly presented after natural infection, thereby guiding the selection of coding regions for mRNA vaccines. It can also be used to assess the risk of epitope escape caused by viral mutations, providing valuable information for vaccine updating and optimization.
2. Tumor Neoantigen Screening
Tumor cells often present tumor-specific mutant peptides, known as neoantigens. Through immunopeptidomics, researchers can directly identify MHC-loaded neoantigens, providing precise targets for personalized cancer vaccine design.
3. Autoimmunity and Tolerance Research
Identification of disease-associated MHC-presented peptides can help elucidate the molecular basis of immune imbalance. This information may also guide the development of therapeutic vaccines, including vaccines designed to induce immune tolerance in autoimmune diseases.
Advantages of MtoZ Biolabs’ Immunopeptidomics Service
MtoZ Biolabs has established a high-throughput immunopeptidomics platform that integrates MHC enrichment technology with high-sensitivity mass spectrometry systems, enabling:
MtoZ Biolabs is committed to providing high-quality research support for vaccine development, immunotherapy, biomarker discovery, and related fields, helping clients accurately identify immune targets with clinical value. As an important bridge connecting molecular antigen presentation with clinical immune intervention, immunopeptidomics is becoming an indispensable tool in vaccine research and development. Its value is expected to become increasingly prominent in future personalized medicine and disease prevention strategies. MtoZ Biolabs will continue to strengthen its technical capabilities in multi-omics integration and immune analysis, providing new support for vaccine science and immunotherapy.
MtoZ Biolabs, an integrated chromatography and mass spectrometry (MS) services provider.
Related Services
How to order?
